Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Ocular cicatricial pemphigoid

Wang, Kaidi; Seitzman, Gerami; Gonzales, John A.

Current Opinion in Ophthalmology: November 2018 - Volume 29 - Issue 6 - p 543–551
doi: 10.1097/ICU.0000000000000517
OCULAR MANIFESTATIONS OF SYSTEMIC DISEASE: Edited by John A. Gonzales

Purpose of review This review offers recommendations for monitoring disease status in ocular cicatricial pemphigoid as well therapeutic options including local and systemic therapies.

Recent findings A negative biopsy on direct immunofluorescence does not preclude a diagnosis of OCP. If a patient's cicatrization is active and/or progressive, systemic immunosuppression should be commenced.

Summary OCP is a chronic systemic autoimmune disease that requires systemic immunosuppression.

Francis I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California, USA

Correspondence to John A. Gonzales, MD, Francis I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, 95 Kirkham Street, San Francisco, CA, USA. E-mail: john.gonzales@ucsf.edu

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.